Biocon received four observations from the US health regulator after a GMP inspection at its API facility in Andhra Pradesh.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/GLMAsV2
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Biocon gets 4 observations from USFDA for Andhra Pradesh facility
0 comments:
Post a Comment